Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Days alive and out of hospital after treatment for oropharyngeal squamous cell carcinoma with primary transoral robotic surgery or radiotherapy - a prospective cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Distribution of microcrack surface density in the human otic capsule

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Manuscript title: the maxillary swing approach - the first Scandinavian experience

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Autologous fibrin sealant co-delivered with antibiotics is a robust method for topical antibiotic treatment after sinus surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Nordic results of cochlear implantation in adults: speech perception and patient reported outcomes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. COVID-19 infection rate among tertiary referral center otorhinolaryngology healthcare workers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Inflammatory response, fluid balance and outcome in emergency high-risk abdominal surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Letter: Enhanced Recovery After Neurosurgery for Brain Tumors - A Critical Reappraisal

    Publikation: Bidrag til tidsskriftLetterpeer review

Vis graf over relationer

BACKGROUND: With the rising incidence of oropharyngeal squamous cell cancer, there is a need to assess the burden of treatment.

AIMS/OBJECTIVES: This study assessed 'days alive and out of hospital' (DAOH) in a cohort of patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with either transoral robotic surgery (TORS) or radiotherapy (RT).

MATERIAL AND METHODS: A prospective cohort study conducted between May 2017-June 2019. Primary outcome was DAOH in the first 30 days after treatment (DAOH30). The secondary outcome was DAOH180.

RESULTS: Forty-four patients were included, 31 treated with TORS and 13 with RT. Patients treated with TORS had a median DAOH30 of 25 (IQR 22.8-26) including a required four-day postoperative stay- and a median DAOH180 of 168 (IQR 163-171.3). In contrast, patients treated with RT had a median DAOH30 of 30 (IQR 26-30) and a DAOH180 of 143 days (IQR 135.5-149).

CONCLUSIONS AND SIGNIFICANCE: DAOH has not been examined in oropharyngeal cancer before. We found, patients overall spent 92.5% of the first 180 days alive and out of hospital. Patients treated with TORS had high DAOH30, which remained high in DAOH180, while patients treated with RT with reduced DAOH30, had reduced DAOH180 calling for further large-scale studies.

OriginalsprogEngelsk
TidsskriftActa Oto-Laryngologica
Vol/bind141
Udgave nummer2
Sider (fra-til)193-196
Antal sider4
ISSN0001-6489
DOI
StatusUdgivet - feb. 2021

ID: 61215026